Understanding Your Child's NEDSGO Diagnosis
At a Glance
NEDSGO is an ultra-rare genetic condition caused by changes in both copies of TBC1D2B. It commonly involves developmental delay, seizures, and gingival overgrowth, so children benefit from coordinated neurology, genetics, dental, and therapy care.
Receiving a diagnosis of Neurodevelopmental Disorder with Seizures and Gingival Overgrowth (NEDSGO) can feel like entering a new world with very few maps. Because this condition is ultra-rare—with fewer than 15 cases reported in medical literature globally—you may have spent years searching for answers [1][2]. This “diagnostic odyssey” is often exhausting and emotional, and it is completely normal to feel a mix of relief at finally having a name for the condition and overwhelming uncertainty about what the future holds [3][4].
What is NEDSGO?
NEDSGO is a genetic condition that primarily affects the brain and the growth of certain oral and facial tissues. It is caused by changes (variants) in both copies of the TBC1D2B gene [5][1]. This gene provides instructions for a protein that helps manage how cells move materials around inside themselves; when this process is disrupted, it can lead to the symptoms seen in NEDSGO [5].
NEDSGO follows an autosomal recessive inheritance pattern. This means a child must inherit one changed copy of the gene from each parent to have the condition [6]. In most cases, the parents are “carriers” who do not have any symptoms themselves because they still have one working copy of the gene [5].
The Core Symptoms (The Triad)
While every child is different, researchers have identified three primary features that occur in most reported individuals with NEDSGO:
- Developmental Delay and Intellectual Disability: Most reported individuals experience delays in reaching milestones like sitting, walking, or speaking [1][2]. Some may experience developmental regression, which is a loss of previously learned skills over time [1].
- Seizures: Approximately 8 of 10 individuals reported in a recent review developed epilepsy (recurring seizures) [1]. The type and severity of these seizures can vary significantly between children [6].
- Gingival Overgrowth: This is the technical term for the thickening or excessive growth of the soft gums (gingiva) [1]. Distinct from this soft-tissue growth, some individuals develop fibrous dysplasia where normal jawbone is replaced by fibrous tissue [6].
Understanding the Course of NEDSGO
Because so few children have been diagnosed with NEDSGO, doctors are still learning about how the condition changes as a child grows.
- What is known: For some children, the condition has been reported to be progressive, meaning symptoms like cognitive ability, tremors, or walking stability may change or worsen over time [6][1]. Brain imaging (MRI) in some cases has shown atrophy, which is a shrinking of certain parts of the brain like the cerebrum or cerebellum [1].
- What is uncertain: There is not yet enough data to predict an inevitable course or the exact long-term outcome for every child [1]. The rarity of the condition means there are no standard, one-size-fits-all treatment protocols [7].
Building Your Care Team
A precise molecular diagnosis is a powerful tool. It allows you to move away from “searching” and toward “managing.” Because NEDSGO affects multiple systems, your child will likely need a multidisciplinary care team [8]. This team often includes:
- Neurologists to manage seizures and monitor brain health.
- Pediatric Dentists or Oral Surgeons to monitor and treat gum overgrowth and jawbone changes.
- Geneticists to help you understand the TBC1D2B variant and its implications for your family.
- Therapists (Physical, Occupational, and Speech) to support your child’s development and daily functioning [9].
When choosing treatments, it is important for your specialists to talk to each other. For example, certain common seizure medications, like phenytoin, are known to cause gum enlargement and may need to be avoided or used with caution in children who already have NEDSGO-related gingival overgrowth [10][11].
The Emotional Impact
Caring for a child with an ultra-rare, complex condition is a monumental task. Parents often report high levels of stress, hypervigilance, and isolation [12][13]. Your feelings of grief, fear, or exhaustion are valid and are shared by many in the rare disease community [14]. You are not just a parent; you have often had to become a care manager and an expert in a disease that many doctors have never seen [12]. Seeking out support groups for rare neurodevelopmental disorders or genetic epilepsy can provide a vital connection to others who understand this unique journey [8][15].
Common questions in this guide
What causes NEDSGO, and how is it passed down?
What are the main signs of NEDSGO in children?
Does NEDSGO get worse over time?
Which specialists should care for a child with NEDSGO?
Can seizure medicines make NEDSGO-related gum overgrowth worse?
What should parents monitor after an NEDSGO diagnosis?
Get notified when new evidence is published on neurodevelopmental disorder with seizures and gingival overgrowth.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Loss of TBC1D2B causes a progressive neurological disorder with gingival overgrowth.
Harms FL, Rexach JE, Efthymiou S, et al.
European journal of human genetics : EJHG 2024; (32(5)):558-566 doi:10.1038/s41431-024-01563-5.
PMID: 38374468 - 2
A Novel Homozygous TBC1D2B Variant Disrupts Functional Domains and Suggests Impaired Rab-GTPase Regulation in Neurodevelopmental Disorder.
Ozturk M, Arslan CB, Akbulut E, et al.
Developmental neurobiology 2025; (85(4)):e22998 doi:10.1002/dneu.22998.
PMID: 40898781 - 3
Impact of developmental and epileptic encephalopathies on caregivers: A literature review.
Gallop K, Lloyd AJ, Olt J, Marshall J
Epilepsy & behavior : E&B 2021; (124()):108324 doi:10.1016/j.yebeh.2021.108324.
PMID: 34607217 - 4
CHD2-related disorders: A conceptual disease model informed by caregiver experience.
SanInocencio C, Prince S, Chandran I, et al.
Epilepsy research 2026; (221()):107735 doi:10.1016/j.eplepsyres.2026.107735.
PMID: 41621282 - 5
Biallelic loss-of-function variants in TBC1D2B cause a neurodevelopmental disorder with seizures and gingival overgrowth.
Harms FL, Parthasarathy P, Zorndt D, et al.
Human mutation 2020; (41(9)):1645-1661 doi:10.1002/humu.24071.
PMID: 32623794 - 6
Biallelic frameshift variant in the TBC1D2B gene in two siblings with progressive gingival overgrowth, fibrous dysplasia of face, and mental deterioration.
Correia-Costa GR, de Leeuw N, Pfundt R, et al.
Clinical genetics 2022; (102(6)):537-542 doi:10.1111/cge.14215.
PMID: 36029130 - 7
Clinical features of PPP2 syndrome type R5D (Jordan's syndrome) to support standardization of care.
Levine AD, Chung WK
Cold Spring Harbor molecular case studies 2023; (9(3)) doi:10.1101/mcs.a006285.
PMID: 37339871 - 8
Exploring Parents' Values in Healthcare Decision-Making for Rare Genetic Neurodevelopmental Disorders: A Qualitative Study to Inform Guideline Development.
Klein Haneveld MJ, Cox L, Embregts PJCM, et al.
Journal of intellectual disability research : JIDR 2026; (70(9)):913-922 doi:10.1111/jir.70150.
PMID: 42571921 - 9
Needs of children with neurodevelopmental disorders and medical complexity: Caregiver perspectives.
Materula D, Currie G, Jia XY, et al.
Research in developmental disabilities 2024; (153()):104815 doi:10.1016/j.ridd.2024.104815.
PMID: 39142086 - 10
Periodontal Management to Improve Oral Health-related Quality of Life in an Adolescent Girl with Phenytoin-induced Gingival Enlargement: A Case Report.
Dawar A, Gumber B, Makker K
International journal of clinical pediatric dentistry 2025; (18(5)):599-605 doi:10.5005/jp-journals-10005-3133.
PMID: 41050299 - 11
Severe Anti-epileptic Drug-induced Gingival Overgrowth in a Physically Disabled Patient.
Kaomongkolgit R, Tantanapornkul W, Jittapiromsak N, et al.
The West Indian medical journal 2015; (65(1)):212-215.
PMID: 26907979 - 12
Using Interpretative Phenomenological Analysis to Explore the Experiences of Mothers Who Have a Child With the Rare Genetic Disorder, HNRNPU-Related Neurodevelopmental Disorder: "Some Days, I Wear a Cape and I'm Super Mom and Some Days, I Have to Hide Under My Cape and I Can't Get Out for a Few Days".
Overton I, Docherty F, Balasubramanian M
Journal of genetic counseling 2026; (35(5)).
PMID: 42922377 - 13
Work-Family Conflict, Parental Stress, and Work Centrality Among Parents of 0-4-Year-Old Children with Neurodevelopmental Disorders.
Gadot L, Segev E, Fine M
Journal of autism and developmental disorders 2026; (56(11)):4417-4428 doi:10.1007/s10803-025-06889-7.
PMID: 40397049 - 14
The mental health and traumatic experiences of mothers of children with 22q11DS.
Finless A, Rideout AL, Xiong T, et al.
European journal of psychotraumatology 2024; (15(1)):2353532 doi:10.1080/20008066.2024.2353532.
PMID: 38780146 - 15
Centering caregiver voices on caregiving needs of children with neurodevelopmental disorders in low-resource settings.
Chansa-Kabali T, Banda-Chalwe M, Lupenga J
PloS one 2025; (20(10)):e0335402 doi:10.1371/journal.pone.0335402.
PMID: 41166333
This page explains NEDSGO for educational purposes only and does not constitute medical advice. Your child’s neurologist, geneticist, and dental specialists should guide diagnosis, medication choices, and care.